Phloretin in Benign Prostate Hyperplasia and Prostate Cancer: A Contemporary Systematic Review

被引:7
作者
Yang, Che-Hsueh [1 ]
Ou, Yen-Chuan [1 ]
Lin, Chi-Chien [2 ]
Lin, Yi-Sheng [1 ]
Tung, Min-Che [1 ]
Yu, Chia-Cheng [3 ]
Lin, Jen-Tai [3 ]
Wen, Chen-Yueh [3 ]
机构
[1] Tungs Taichung MetroHarbor Hosp, Dept Surg, Div Urol, Taichung 435, Taiwan
[2] Natl Chung Hsing Univ, iEGG & Anim Biotechnol Ctr, Inst Biomed Sci, Taichung 402, Taiwan
[3] Kaohsiung Vet Gen Hosp, Dept Surg, Div Urol, Kaohsiung 813, Taiwan
来源
LIFE-BASEL | 2022年 / 12卷 / 07期
关键词
phloretin; pharmacology; therapeutic use; prostatic neoplasms; drug therapy; prostatic hyperplasia; male; NF-KAPPA-B; PROLIFERATIVE INFLAMMATORY ATROPHY; EPITHELIAL-MESENCHYMAL TRANSITION; ANDROGEN RECEPTOR EXPRESSION; ERECTILE DYSFUNCTION; DEPRIVATION THERAPY; CELL-PROLIFERATION; GENE AMPLIFICATION; 2ND-LINE THERAPY; CPG ISLAND;
D O I
10.3390/life12071029
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Currently, medication for benign prostate hyperplasia (BPH) and prostate cancer (PCa) are mainly based on modulating the hormone and nervous systems. However, side effects often affect patients, and might decrease their commitment to continuing the medication and lower their quality of life. Some studies have indicated that chronic inflammation might be the cause of BPH and PCa. Based on this hypothesis, the effect of phloretin, a potent anti-inflammatory and anti-oxidative flavonoid, has been researched since 2010. Results from animal and in-vitro studies, obtained from databases, also indicate that the use of phloretin in treating BPH and PCa is promising. Due to its effect on inflammatory cytokines, apoptosis or anti-apoptosis, reactive oxygen species, anti-oxidant enzymes and oxidative stress, phloretin is worthy of further study in human clinical trials regarding safety and effective dosages.
引用
收藏
页数:15
相关论文
共 89 条
[1]   A role for epithelial-mesenchymal transition in the etiology of benign prostatic hyperplasia [J].
Alonso-Magdalena, Paloma ;
Broessner, Clemens ;
Reiner, Angelika ;
Cheng, Guojun ;
Sugiyama, Nobuhiro ;
Warner, Margaret ;
Gustafsson, Jan-Ake .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (08) :2859-2863
[2]   Docetaxel-related side effects and their management [J].
Baker, Jackie ;
Ajani, Jaffer ;
Scotte, Florian ;
Winther, Dorte ;
Martin, Miguel ;
Aapro, Matti S. ;
von Minckwitz, Gunter .
EUROPEAN JOURNAL OF ONCOLOGY NURSING, 2009, 13 (01) :49-59
[3]   Molecular biomarker in prostate cancer: The role of CpG island hypermethylation [J].
Bastian, PJ ;
Yegnasubramanian, S ;
Palapattu, GS ;
Rogers, CG ;
Lin, XH ;
De Marzo, AM ;
Nelson, WG .
EUROPEAN UROLOGY, 2004, 46 (06) :698-708
[4]   Prostatic Atrophy. Clinicopathological Significance [J].
Billis, Athanase .
INTERNATIONAL BRAZ J UROL, 2010, 36 (04) :401-409
[5]   Epidemiology and risk factors of lower urinary tract symptoms/benign prostatic hyperplasia and erectile dysfunction [J].
Calogero, Aldo E. ;
Burgio, Giovanni ;
Condorelli, Rosita A. ;
Cannarella, Rossella ;
La Vignera, Sandro .
AGING MALE, 2019, 22 (01) :12-19
[6]   Biochemical Basis of Anti-Cancer-Effects of PhloretinA Natural Dihydrochalcone [J].
Choi, Bu Young .
MOLECULES, 2019, 24 (02)
[7]   Nutraceutical treatment and prevention of benign prostatic hyperplasia and prostate cancer [J].
Cicero, Arrigo F. G. ;
Allkanjari, Olta ;
Busetto, Gian Maria ;
Cai, Tommaso ;
Largana, Gaetano ;
Magri, Vittorio ;
Perletti, Gianpaolo ;
Della Cuna, Francesco Saverio Robustelli ;
Russo, Giorgio Ivan ;
Stamatiou, Kostantinos ;
Trinchieri, Alberto ;
Vitalone, Annabella .
ARCHIVIO ITALIANO DI UROLOGIA E ANDROLOGIA, 2019, 91 (03) :139-152
[8]   Metabolomic Profiling and Antioxidant Activity of Fruits Representing Diverse Apple and Pear Cultivars [J].
Commisso, Mauro ;
Bianconi, Martino ;
Poletti, Stefania ;
Negri, Stefano ;
Munari, Francesca ;
Ceoldo, Stefania ;
Guzzo, Flavia .
BIOLOGY-BASEL, 2021, 10 (05)
[9]   Analyzing the Androgen Receptor Interactome in Prostate Cancer: Implications for Therapeutic Intervention [J].
Dahiya, Ujjwal R. ;
Heemers, Hannelore, V .
CELLS, 2022, 11 (06)
[10]   The role of androgens and the androgen receptor in prostate cancer [J].
Debes, JD ;
Tindall, DJ .
CANCER LETTERS, 2002, 187 (1-2) :1-7